GP-01CR01

N/A

Report date: 2022/01/26 12:16:40
NME

Base Information

Drug NameGP-01CR01
Drug Alias NameGP-01CR01
ClassificationOther
Mechanisms of ActionBeta-2 adrenergic receptor antagonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsSolid tumoursLeukemia, Myeloid, AcuteNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGPCR Therapeutics USA Inc
China Registration ClassN/A

Develop Information

Active CompaniesGPCR Therapeutics USA Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursLeukemia, Myeloid, AcuteNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A